跳至主要内容
临床试验/NCT00182351
NCT00182351已完成3 期

Evaluation of the Safety, Efficacy and Cost-Effectiveness of Two Strategies for the Diagnosis of Deep Vein Thrombosis

Hamilton Health Sciences Corporation6 个研究点 分布在 1 个国家目标入组 810 人开始时间: 1996年4月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
810
试验地点
6
主要终点
safety of withholding anticoagulants

研究概览

简要总结

To determine whether d-dimer testing can be used to simplify and reduce the costs of the diagnostic approach to patients with clinically suspected deep vein thrombosis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
0 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • first suspected deep vein thrombosis
  • no previous venous thromboembolism
  • referred to thromboembolism outpatient clinic

排除标准

  • comorbid condition limiting survival to less than six months
  • contraindication to venography (contrast allergy, etc.)
  • receiving long term warfarin therapy
  • receiving full dose heparin therapy for more than 48 hours
  • absence of symptoms during the five days immediately prior to presentation
  • symptoms of pulmonary embolism
  • pregnancy
  • geographic inaccessibility which precludes follow-up

结局指标

主要结局

safety of withholding anticoagulants

次要结局

  • deep vein thrombosis
  • pulmonary embolism
  • death

研究者

申办方类型
Other

研究点 (6)

Loading locations...

相似试验